Safety data from an expanded access program (EAP) of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (MEL) Meeting Abstract
| Authors: | Chapman, P. B.; Sznol, M.; Lao, C. D.; Gonzalez, R.; Daniels, G. A.; Thompson, J. A.; Kudchadkar, R. R.; Sharfman, W. H.; Atkins, M. B.; Pavlick, A. C.; Infante, J. R.; Kim, K. B.; Weber, J. S.; Nair, S.; Cowey, L.; Lipson, E. J.; Lee, S.; Avila, A.; Hodi, S. |
| Abstract Title: | Safety data from an expanded access program (EAP) of nivolumab (NIVO) in combination with ipilimumab (IPI) in patients with advanced melanoma (MEL) |
| Meeting Title: | COSA's 43rd Annual Scientific Meeting |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 12 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2016 Nov 15-17 |
| Meeting Location: | Queensland, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2016-11-01 |
| Start Page: | 119 |
| Language: | English |
| ACCESSION: | WOS:000387769900169 |
| PROVIDER: | wos |
| DOI: | 10.1111/ajco.12646 |
| Notes: | Meeting Abstract: 219 -- Source: Wos |
